Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

BenRalizumab Effect on Airway Remodeling in Severe asTHma — Stella

Home/Asthma; Eosinophilic/BenRalizumab Effect on Airway Remodeling in Severe asTHma

View on ClinicalTrials.gov

Recruiting

Back to Asthma; Eosinophilic trials

BenRalizumab Effect on Airway Remodeling in Severe asTHma

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Greece

Pulmonary Clinic, Aristotle University of Thessaloniki, George Papanikolaou Hospital, Thessaloniki

Key details

Phase

Post-approval study

Sponsor

Aristotle University Of Thessaloniki

Collaborators

Pulmonary Clinic, University of Ioannina, Pulmonary Clinic, Democritus University of Thrace

Enrollment target

~45 participants

Started

March 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 85 Years

Last updated March 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.